Bone and soft tissue ablation

Ryan C B Foster, Joseph Stavas

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Bone and soft tissue tumor ablation has reached widespread acceptance in the locoregional treatment of various benign and malignant musculoskeletal (MSK) lesions. Many principles of ablation learned elsewhere in the body are easily adapted to the MSK system, particularly the various technical aspects of probe/antenna design, tumoricidal effects, selection of image guidance, and methods to reduce complications. Despite the common use of thermal and chemical ablation procedures in bone and soft tissues, there are few large clinical series that show longitudinal benefit and cost-effectiveness compared with conventional methods, namely, surgery, external beam radiation, and chemotherapy. Percutaneous radiofrequency ablation of osteoid osteomas has been evaluated the most and is considered a first-line treatment choice for many lesions. Palliation of painful metastatic bone disease with thermal ablation is considered safe and has been shown to reduce pain and analgesic use while improving quality of life for cancer patients. Procedure-related complications are rare and are typically easily managed. Similar to all interventional procedures, bone and soft tissue lesions require an integrated approach to disease management to determine the optimum type of and timing for ablation techniques within the context of the patient care plan.

Original languageEnglish
Pages (from-to)167-179
Number of pages13
JournalSeminars in Interventional Radiology
Volume31
Issue number2
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Bone and Bones
Cost-Benefit Analysis
Hot Temperature
Ablation Techniques
Osteoid Osteoma
Musculoskeletal System
Bone Diseases
Disease Management
Analgesics
Neoplasms
Patient Care
Quality of Life
Radiation
Drug Therapy
Pain
Therapeutics

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Bone and soft tissue ablation. / Foster, Ryan C B; Stavas, Joseph.

In: Seminars in Interventional Radiology, Vol. 31, No. 2, 2014, p. 167-179.

Research output: Contribution to journalArticle

Foster, Ryan C B ; Stavas, Joseph. / Bone and soft tissue ablation. In: Seminars in Interventional Radiology. 2014 ; Vol. 31, No. 2. pp. 167-179.
@article{ec7bf71a7eab4bff866f41ca35432ea6,
title = "Bone and soft tissue ablation",
abstract = "Bone and soft tissue tumor ablation has reached widespread acceptance in the locoregional treatment of various benign and malignant musculoskeletal (MSK) lesions. Many principles of ablation learned elsewhere in the body are easily adapted to the MSK system, particularly the various technical aspects of probe/antenna design, tumoricidal effects, selection of image guidance, and methods to reduce complications. Despite the common use of thermal and chemical ablation procedures in bone and soft tissues, there are few large clinical series that show longitudinal benefit and cost-effectiveness compared with conventional methods, namely, surgery, external beam radiation, and chemotherapy. Percutaneous radiofrequency ablation of osteoid osteomas has been evaluated the most and is considered a first-line treatment choice for many lesions. Palliation of painful metastatic bone disease with thermal ablation is considered safe and has been shown to reduce pain and analgesic use while improving quality of life for cancer patients. Procedure-related complications are rare and are typically easily managed. Similar to all interventional procedures, bone and soft tissue lesions require an integrated approach to disease management to determine the optimum type of and timing for ablation techniques within the context of the patient care plan.",
author = "Foster, {Ryan C B} and Joseph Stavas",
year = "2014",
doi = "10.1055/s-0034-1373791",
language = "English",
volume = "31",
pages = "167--179",
journal = "Seminars in Interventional Radiology",
issn = "0739-9529",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Bone and soft tissue ablation

AU - Foster, Ryan C B

AU - Stavas, Joseph

PY - 2014

Y1 - 2014

N2 - Bone and soft tissue tumor ablation has reached widespread acceptance in the locoregional treatment of various benign and malignant musculoskeletal (MSK) lesions. Many principles of ablation learned elsewhere in the body are easily adapted to the MSK system, particularly the various technical aspects of probe/antenna design, tumoricidal effects, selection of image guidance, and methods to reduce complications. Despite the common use of thermal and chemical ablation procedures in bone and soft tissues, there are few large clinical series that show longitudinal benefit and cost-effectiveness compared with conventional methods, namely, surgery, external beam radiation, and chemotherapy. Percutaneous radiofrequency ablation of osteoid osteomas has been evaluated the most and is considered a first-line treatment choice for many lesions. Palliation of painful metastatic bone disease with thermal ablation is considered safe and has been shown to reduce pain and analgesic use while improving quality of life for cancer patients. Procedure-related complications are rare and are typically easily managed. Similar to all interventional procedures, bone and soft tissue lesions require an integrated approach to disease management to determine the optimum type of and timing for ablation techniques within the context of the patient care plan.

AB - Bone and soft tissue tumor ablation has reached widespread acceptance in the locoregional treatment of various benign and malignant musculoskeletal (MSK) lesions. Many principles of ablation learned elsewhere in the body are easily adapted to the MSK system, particularly the various technical aspects of probe/antenna design, tumoricidal effects, selection of image guidance, and methods to reduce complications. Despite the common use of thermal and chemical ablation procedures in bone and soft tissues, there are few large clinical series that show longitudinal benefit and cost-effectiveness compared with conventional methods, namely, surgery, external beam radiation, and chemotherapy. Percutaneous radiofrequency ablation of osteoid osteomas has been evaluated the most and is considered a first-line treatment choice for many lesions. Palliation of painful metastatic bone disease with thermal ablation is considered safe and has been shown to reduce pain and analgesic use while improving quality of life for cancer patients. Procedure-related complications are rare and are typically easily managed. Similar to all interventional procedures, bone and soft tissue lesions require an integrated approach to disease management to determine the optimum type of and timing for ablation techniques within the context of the patient care plan.

UR - http://www.scopus.com/inward/record.url?scp=84901277545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901277545&partnerID=8YFLogxK

U2 - 10.1055/s-0034-1373791

DO - 10.1055/s-0034-1373791

M3 - Article

AN - SCOPUS:84901277545

VL - 31

SP - 167

EP - 179

JO - Seminars in Interventional Radiology

JF - Seminars in Interventional Radiology

SN - 0739-9529

IS - 2

ER -